Management Team

Melior’s management has combined experience of over 150 years of drug discovery and development know-how. Our management and staff have spent years, prior to Melior, working in the most recognized multinational pharmaceutical companies. All of our management team has participated in therapeutic programs that have progressed to advanced clinical stage.

Andrew Reaume, PhD, MBA

President and CEO,
Co-Founder

Patty Ferrante

Chief Operating Officer

Weina Cong, PhD

Director of Cardiovascular & Metabolic Disease

Gennady N. Smagin, MD, PhD

Director of Pharmacology

John A. Gruner, PhD

Director of Neurophysiology

Amy DiCamillo

Director of Scientific Operations

Alexandra Liddane

Senior Scientist

Erin Davis

Director of Lab Operations